IMC Chicago’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Buy
156,600
+35,300
+29% +$394K ﹤0.01% 3410
2026
Q1
$1.31M Sell
121,300
-66,500
-35% -$569K ﹤0.01% 2996
2025
Q4
$1.15M Buy
187,800
+141,600
+306% +$845K ﹤0.01% 2868
2025
Q3
$239K Sell
46,200
-11,900
-20% -$68.4K ﹤0.01% 3495
2025
Q2
$345K Sell
58,100
-400
-0.7% -$2.41K ﹤0.01% 3051
2025
Q1
$481K Sell
58,500
-19,100
-25% -$160K ﹤0.01% 2680
2024
Q4
$641K Buy
77,600
+16,100
+26% +$129K ﹤0.01% 2619
2024
Q3
$470K Buy
61,500
+8,900
+17% +$82K ﹤0.01% 2442
2024
Q2
$545K Buy
+52,600
New +$577K ﹤0.01% 2259

Other funds holding PTEN

IMC Chicago's PTEN Position: Q2 2026 in Review

IMC Chicago opened a new position in Patterson-UTI (PTEN) in Q2 2026: 18,657 shares worth $171K. The stake represents ﹤0.01% of the portfolio and ranks #5762 among its holdings. This is a return to the name: IMC Chicago previously reported a position in PTEN as recently as Q3 2025.

IMC Chicago first reported a position in PTEN in Q1 2025 and has held it in 4 quarters since. The position peaked at $385K in Q3 2025. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • IMC Chicago held 18,657 shares of Patterson-UTI worth $171K as of Q2 2026.
  • Patterson-UTI was a new IMC Chicago position in Q2 2026.
  • Patterson-UTI made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5762 holding.
  • IMC Chicago first reported a position in Patterson-UTI in Q1 2025 and has held it in 4 quarters since.
  • IMC Chicago's Patterson-UTI position peaked at $385K in Q3 2025.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.